Clinical Outcomes of Pharmacological Venous Thromboembolism Prophylaxis Following Arthroplasty and Hip Fracture Surgery: A Prospective Study

Background: Major orthopaedic procedures, including total knee replacement (TKR), total hip replacement (THR), and hip fracture surgery, are associated with an increased risk of postoperative venous thromboembolism (VTE). Pharmacological thromboprophylaxis is widely used to reduce the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE), although anticoagulant therapy may be associated with bleeding and wound-related complications. Aim: To evaluate the clinical outcomes of pharmacological VTE prophylaxis among patients undergoing arthroplasty and hip fracture surgery. Materials and Methods: A prospective observational study was conducted in the Department of Orthopaedics, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, from March 2025 to February 2026. A total of 78 patients undergoing TKR, THR, or hip fracture surgery were included after obtaining informed consent. Patients with preoperative VTE, pregnancy, GFR <30 mL/min, cirrhosis, thrombocytopenia, and major pre-existing risk factors for thromboembolism were excluded. All participants received pharmacological prophylaxis with enoxaparin. Patients were followed postoperatively for the development of DVT, PE, bleeding complications, wound hematoma, lower-limb oedema, and mortality. Data were analysed using appropriate descriptive and inferential statistical methods, with p<0.05 considered statistically significant. Results: Among the 78 patients, 66.7% were females and 33.3% were males. Osteoarthritis of the knee was the most common diagnosis (78.2%), followed by NOF fracture (15.4%). Bilateral TKR was performed in 39.7% and unilateral TKR in 38.5% of patients. Cemented arthroplasty was performed in 83.3%, while 16.7% underwent uncemented procedures. All patients received enoxaparin prophylaxis. Wound hematoma and bilateral lower-limb oedema were observed in 3.8% of patients. No proximal or distal DVT was detected. Pulmonary embolism occurred in 1.3% of patients, with the affected patient dying on the fifth postoperative day. Conclusion: Pharmacological VTE prophylaxis with enoxaparin was associated with a low incidence of clinically evident thromboembolic and bleeding complications in patients undergoing major orthopaedic surgery. However, the occurrence of fatal PE despite prophylaxis highlights the need for continued postoperative vigilance and individualized assessment of thromboembolic risk. Larger prospective studies with longer follow-up are required to further establish the effectiveness and safety of pharmacological thromboprophylaxis in orthopaedic patients.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-17
DOI
https://doi.org/10.25258/ijddt.16.80s.104
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Outcomes of Pharmacological Venous Thromboembolism Prophylaxis Following Arthroplasty and Hip Fracture Surgery: A Prospective Study

Vankamaddi Vishnuvardhan, Rohan Raj, Pratiksha Pratiksha
International Journal of Drug Delivery Technology
Venous Thromboembolism Diagnosis and Management
article

Clinical Outcomes of Pharmacological Venous Thromboembolism Prophylaxis Following Arthroplasty and Hip Fracture Surgery: A Prospective Study

Vankamaddi Vishnuvardhan, Rohan Raj, Pratiksha Pratiksha
article en

Abstract

Background: Major orthopaedic procedures, including total knee replacement (TKR), total hip replacement (THR), and hip fracture surgery, are associated with an increased risk of postoperative venous thromboembolism (VTE). Pharmacological thromboprophylaxis is widely used to reduce the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE), although anticoagulant therapy may be associated with bleeding and wound-related complications. Aim: To evaluate the clinical outcomes of pharmacological VTE prophylaxis among patients undergoing arthroplasty and hip fracture surgery. Materials and Methods: A prospective observational study was conducted in the Department of Orthopaedics, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, from March 2025 to February 2026. A total of 78 patients undergoing TKR, THR, or hip fracture surgery were included after obtaining informed consent. Patients with preoperative VTE, pregnancy, GFR <30 mL/min, cirrhosis, thrombocytopenia, and major pre-existing risk factors for thromboembolism were excluded. All participants received pharmacological prophylaxis with enoxaparin. Patients were followed postoperatively for the development of DVT, PE, bleeding complications, wound hematoma, lower-limb oedema, and mortality. Data were analysed using appropriate descriptive and inferential statistical methods, with p<0.05 considered statistically significant. Results: Among the 78 patients, 66.7% were females and 33.3% were males. Osteoarthritis of the knee was the most common diagnosis (78.2%), followed by NOF fracture (15.4%). Bilateral TKR was performed in 39.7% and unilateral TKR in 38.5% of patients. Cemented arthroplasty was performed in 83.3%, while 16.7% underwent uncemented procedures. All patients received enoxaparin prophylaxis. Wound hematoma and bilateral lower-limb oedema were observed in 3.8% of patients. No proximal or distal DVT was detected. Pulmonary embolism occurred in 1.3% of patients, with the affected patient dying on the fifth postoperative day. Conclusion: Pharmacological VTE prophylaxis with enoxaparin was associated with a low incidence of clinically evident thromboembolic and bleeding complications in patients undergoing major orthopaedic surgery. However, the occurrence of fatal PE despite prophylaxis highlights the need for continued postoperative vigilance and individualized assessment of thromboembolic risk. Larger prospective studies with longer follow-up are required to further establish the effectiveness and safety of pharmacological thromboprophylaxis in orthopaedic patients.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Saveetha University (IN)
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon